Chemiluminescence immunoassay (CLIA) (Analytical method)

Go to Analytical method classification
ID44
NameChemiluminescence immunoassay (CLIA)
ClassificationAnalytical methods > Ligand binding assay > Immunoassay

Publications with Chemiluminescence immunoassay (CLIA)

TitleFirst authorYear
Validity and reproducibility of folate and vitamin B(12) intakes estimated from a self-administered diet history questionnaire in Japanese pregnant womenShiraishi2012
Effect of cooking loss in the assessment of vitamin intake for epidemiological data in JapanKobayashi2011
Validation of the assessment of folate and vitamin B12 intake in women of reproductive age: the method of triadsVerkleij-Hagoort2007
Validation of a food frequency questionnaire to assess folate intake of Dutch elderly peoplevan de Rest2007
Folate intake assessment: validation of a new approachYen2003
Seasonal variations in the levels of PAH–DNA adducts in young adults living in Mexico CityGarcia-Suastegui2011
Intraindividual variation in plasma 25-hydroxyvitamin D measures 5 years apart among postmenopausal womenMeng2012
Reproducibility of serum 25-hydroxyvitamin d and vitamin D-binding protein levels over time in a prospective cohort study of black and white adultsSonderman2012
Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialHofmann2010
Reliability of selected antioxidants and compounds involved in one-carbon metabolism in two Dutch cohortsLeenders2013
Intra- and inter-individual variations of blood and urinary water-soluble vitamins in Japanese young adults consuming a semi-purified diet for 7 daysShibata2009
Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal womenCheng2017
Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention TrialKristal2014
Vitamin D status and skin cancer risk independent of time outdoors: 11-year prospective study in an Australian communityvan der Pols2013
Serum 25-hydroxyvitamin d and cancer risk in older adults: results from a large German prospective cohort studyOrdonez-Mena2013
Plasma 25-hydroxyvitamin D and risk of non-melanoma and melanoma skin cancer: a prospective cohort studyAfzal2013
Total and Free Circulating Vitamin D and Vitamin D-Binding Protein in Relation to Colorectal Cancer Risk in a Prospective Study of African AmericansAndersen2017
Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 YearsEliassen2016
Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening TrialWeinstein2015
Vitamin D-binding protein and pancreatic cancer: a nested case-control studyPiper2015
Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention TrialSchenk2014
Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinomaMondul2014
Serum vitamin D, vitamin D binding protein, and risk of colorectal cancerAnic2014
Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancerWeinstein2013
The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal womenNeuhouser2012
Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancerMondul2012
Serum vitamin D and risk of bladder cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening trialMondul2012
Pre-diagnostic circulating vitamin D and risk of melanoma in menMajor2012
Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control studyWeinstein2011
Serum 25-hydroxyvitamin D and risks of colon and rectal cancer in Finnish menWeinstein2011
Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish menArem2011
Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort studyWoolcott2010
Serum vitamin D and risk of bladder cancerMondul2010
Serum 25(OH) vitamin D and risk of breast cancer: a nested case-control study from the French E3N cohortEngel2010
Association of prediagnostic serum vitamin D levels with the development of basal cell carcinomaAsgari2010
Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition CohortMcCullough2009
Plasma Riboflavin and Vitamin B-6, but Not Homocysteine, Folate, or Vitamin B-12, Are Inversely Associated with Breast Cancer Risk in the European Prospective Investigation into Cancer and Nutrition-Varese CohortAgnoli2016
Plasma folate and risk of colorectal cancer in a nested case-control study: the Japan Public Health Center-based prospective studyOtani2008
Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in womenLin2008
Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer CancersZheng2010
Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer CancersZeleniuch-Jacquotte2010
Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer CancersStolzenberg-Solomon2010
Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer CancersPurdue2010
Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer CancersGallicchio2010
Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer CancersAbnet2010
Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancerAfzal2013
In older men, lower plasma 25-hydroxyvitamin D is associated with reduced incidence of prostate, but not colorectal or lung cancerWong2014
Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control studyScarmo2013
Weight Status and Alcohol Intake Modify the Association between Vitamin D and Breast Cancer RiskDeschasaux2016
Plasma folate, vitamin B-6, and vitamin B-12 and breast cancer risk in BRCA1- and BRCA2-mutation carriers: a prospective studyKim2016
Serum 25-hydroxyvitamin D and breast cancer in the military: a case-control study utilizing pre-diagnostic serumMohr2013
Pre-diagnostic vitamin D concentrations and cancer risks in older individuals: an analysis of cohorts participating in the CHANCES consortiumOrdonez-Mena2016
Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control studyAlbanes2011
Association of 25-Hydroxyvitamin D with Liver Cancer Incidence and Chronic Liver Disease Mortality in Finnish Male Smokers of the ATBC StudyLai2018
Plasma 25-hydroxyvitamin D concentration and subsequent risk of total and site specific cancers in Japanese population: large case-cohort study within Japan Public Health Center-based Prospective Study cohortBudhathoki2018
Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 CohortsMcCullough2018
Associations of serum 25-hydroxyvitamin D level with incidence of lung cancer and histologic types in Norwegian adults: a case-cohort analysis of the HUNT studySun2018
High plasma 25-hydroxyvitamin D and high risk of nonmelanoma skin cancer: a Mendelian randomization study of 97 849 individualsWinslow2018

Biomarker data

Measurements of biomarkers by Chemiluminescence immunoassay (CLIA)

Concentration values

IDParent IDDepthSubject groupPopulationCountryCohortBiomarker Time definitionBiospecimenAnalytical methodBiomarkerBiomarker detailMeasurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianConverted unitAdjustment typeAdjusted onRegressed onExpressed asPublication

Reproducibility values

IDExcretion IDSubject groupPopulationCountryCohortBiomarker Time definitionBiospecimenAnalytical methodBiomarkerBiomarker detailArithmetic meanGeometric meanMedianUnitAdjusted onReproducibility sizeICCICC 95% CI lowerICC 95% CI upperCV% WSCV% BSVAR WSVAR BSPublication

Associations of biomarkers measured by Chemiluminescence immunoassay (CLIA) and exposures

Correlation values

IDIntake IDExcretion IDSubject groupPopulationCountryCohortIntake Time definitionIntake Assessment methodIntakeIntake detailSupplement intakes included?Intake Arithmetic meanIntake Geometric meanIntake MedianIntake UnitIntake Adjusted onBiomarker Time definitionBiospecimenAnalytical methodBiomarkerBiomarker detailBiomarker Arithmetic meanBiomarker Geometric meanBiomarker MedianBiomarker UnitBiomarker Adjusted onCorrelation sizeCorrelation typeCorrelation valueCorrelation 95% CI lowerCorrelation 95% CI upperCorrelation p-valueSignificant?Measurement adjustmentDeattenuated?CovariatesPublication

Metabolomic associations

IDIntake IDExcretion IDSubject groupPopulationCountryCohortNo. of subjectsIntake Assessment methodIntakeIntervention doseBiospecimenAnalytical methodBiomarkerStructural identificationFeature selectionArea under curveSensitivitySpecificityPLS-DA VIPBeta coefficientBeta coefficient p-valueANOVA p-valuePublication

Associations of biomarkers measured by Chemiluminescence immunoassay (CLIA) and cancer risk

Cancer associations

IDExcretion IDSubject groupPopulationCountryCohortNo. of subjectsNo. of casesNo. of controlsBiospecimenAnalytical methodBiomarkerBiomarker detailCancerStudy designPublication